Without prejudice to that conclusion, it is appropriate to obtain further information on certain specific points. Article 6(1) of Directive 91/414/EEC provides that inclusion of a substance in Annex I may be subject to conditions. Therefore, it is appropriate to require that the applicant submit further confirmatory information as regards: the specification of the technical material, as commercially manufactured, including appropriate analytical data, the relevance of the impurities, comparison and verification of the test material used in the mammalian toxicity and ecotoxicity dossiers against the specification of the technical material, analytical methods for the monitoring of the metabolite M6 [2-{[anilino(oxo)acetyl]sulfanyl}ethyl acetate.] in soil, groundwater and surface water and for the monitoring of metabolite M9 [(2RS)-2-hydroxy-2-methyl-N-phenyl-1,4-oxathiane-3-carboxamide 4-oxide.] in groundwater, additional values regarding the period required for 50 percent dissipation in soil for the soil metabolites P/V-54 [2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxamide 4-oxide.] and P/V-55 [2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxamide 4,4-dioxide.], rotational crop metabolism, the long-term risk to granivorous birds, granivorous mammals and herbivorous mammals and the relevance for ground water of the soil metabolites P/V-54, P/V-55 and M9 if carboxin is classified under Regulation (EC) No 1272/2008 of the European Parliament and of the Council [OJ L 353, 31.12.2008, p. 1.] as ‘suspected of causing cancer’.
Recital 7, Directive (EU) 2011/52
In forcesince 20 Apr 2011